SEC Comment Letter for Evolent Health, Inc. (EVH) (CIK 0001628908) (EVH) — Nov 9, 2016
Evolent Health, Inc. (EVH) (CIK 0001628908)
Date: Nov. 9, 2016 · CIK: 0001628908 · Accession: 0000000000-16-100304
AI Filing Summary & Sentiment
Letter
Mail Stop 3233 November 8, 2016 VIA E -MAIL Mr. Nicholas McGrane Chief Financial Officer Evolent Health, Inc. 800 N. Glebe Road, Suite 500 Arlington, Virginia 22203
Re: Evolent Health , Inc. Form 8-K dated August 4, 2016 Filed August 4, 2016 File No. 001 -37415
Dear Mr. McGrane :
We have completed our review of your filing . We remind you that the company and its management are responsible for the accuracy and adequacy of the ir disclosure s, notwithstanding any review, comments, action or absence of action by the staff .
Sincerely,
/s/ Daniel L. Gordon
Show Raw Text
Mail Stop 3233
November 8, 2016
VIA E -MAIL
Mr. Nicholas McGrane
Chief Financial Officer
Evolent Health, Inc.
800 N. Glebe Road, Suite 500
Arlington, Virginia 22203
Re: Evolent Health , Inc.
Form 8-K dated August 4, 2016
Filed August 4, 2016
File No. 001 -37415
Dear Mr. McGrane :
We have completed our review of your filing . We remind you that the company and its
management are responsible for the accuracy and adequacy of the ir disclosure s, notwithstanding
any review, comments, action or absence of action by the staff .
Sincerely,
/s/ Daniel L. Gordon
Daniel L. Gordon
Senior Assistant Chief Accountant
Office of Real Estate and
Commodities